Sevoflurane, a sigh of relief in COVID-19?
- PMID: 32416995
- PMCID: PMC7252148
- DOI: 10.1016/j.bja.2020.04.076
Sevoflurane, a sigh of relief in COVID-19?
Keywords: ARDS; COVID-19; ICU; sedation; sepsis; sevoflurane; volatile anaesthetic.
Similar articles
-
Sevoflurane may not be a complete sigh of relief in COVID-19.Br J Anaesth. 2020 Dec;125(6):e487-e488. doi: 10.1016/j.bja.2020.09.012. Epub 2020 Sep 16. Br J Anaesth. 2020. PMID: 33012516 Free PMC article. No abstract available.
-
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.Intensive Care Med. 2020 Aug;46(8):1563-1566. doi: 10.1007/s00134-020-06154-8. Epub 2020 Jun 25. Intensive Care Med. 2020. PMID: 32588067 Free PMC article. Review.
-
Airway management and ventilation principles in COVID-19 patients.J Clin Anesth. 2020 Oct;65:109877. doi: 10.1016/j.jclinane.2020.109877. Epub 2020 May 19. J Clin Anesth. 2020. PMID: 32446177 Free PMC article. No abstract available.
-
Regulating inspiratory pressure to individualise tidal volumes in a simulated two-patient, one-ventilator system.Br J Anaesth. 2020 Oct;125(4):e366-e368. doi: 10.1016/j.bja.2020.06.043. Epub 2020 Jun 30. Br J Anaesth. 2020. PMID: 32718725 Free PMC article. No abstract available.
-
Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey.Crit Care. 2020 Aug 21;24(1):516. doi: 10.1186/s13054-020-03240-7. Crit Care. 2020. PMID: 32825837 Free PMC article. Review. No abstract available.
Cited by
-
Sevoflurane may not be a complete sigh of relief in COVID-19.Br J Anaesth. 2020 Dec;125(6):e487-e488. doi: 10.1016/j.bja.2020.09.012. Epub 2020 Sep 16. Br J Anaesth. 2020. PMID: 33012516 Free PMC article. No abstract available.
-
Oxygen Supply in Hospitals: Requisites in the Current Pandemic.Anesth Essays Res. 2021 Jul-Sep;15(3):253-256. doi: 10.4103/aer.aer_116_21. Epub 2022 Feb 7. Anesth Essays Res. 2021. PMID: 35320955 Free PMC article. Review.
-
Sevoflurane administration from extracorporeal membrane oxygenation via the AnaConDa device for a patient with COVID-19: A breakthrough solution for the shortage of intravenous anesthetics.Heart Lung. 2022 Nov-Dec;56:70-73. doi: 10.1016/j.hrtlng.2022.06.015. Epub 2022 Jun 16. Heart Lung. 2022. PMID: 35780572 Free PMC article.
-
Mild to Severe Neurological Manifestations of COVID-19: Cases Reports.Int J Environ Res Public Health. 2021 Apr 1;18(7):3673. doi: 10.3390/ijerph18073673. Int J Environ Res Public Health. 2021. PMID: 33915937 Free PMC article.
-
Thoracic Anesthesia during the COVID-19 Pandemic: 2021 Updated Recommendations by the European Association of Cardiothoracic Anaesthesiology and Intensive Care (EACTAIC) Thoracic Subspecialty Committee.J Cardiothorac Vasc Anesth. 2021 Dec;35(12):3528-3546. doi: 10.1053/j.jvca.2021.07.027. Epub 2021 Jul 27. J Cardiothorac Vasc Anesth. 2021. PMID: 34479782 Free PMC article.
References
-
- WHO Coronavirus disease 2019 (COVID-19) situation report-93. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... Available from:
-
- Ferrando C., Aguilar G., Piqueras L., Soro M., Moreno J., Belda F.J. Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study. Eur J Anaesthesiol. 2013;30:455–463. - PubMed
-
- Laferriere-Langlois P., d'Aragon F., Manzanares W. Halogenated volatile anesthetics in the intensive care unit: current knowledge on an upcoming practice. Minerva Anestesiol. 2017;83:737–748. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources